🇺🇸 FDA
Patent

US 6316206

Method for screening comprising cells expressing the CNTF receptor

expired A61KA61K38/00

Quick answer

US patent 6316206 (Method for screening comprising cells expressing the CNTF receptor) held by REGENERON PHARMACEUTICALS, INC. expires Mon Nov 08 2021 00:00:00 GMT+0000 (Coordinated Universal Time). Status: expired.

Key facts

Applicant
REGENERON PHARMACEUTICALS, INC.
Grant date
Tue Nov 13 2001 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Nov 08 2021 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
1
CPC classes
A61K, A61K38/00